Reflections and speculations on refractory migraine: why do some patients fail to improve with currently available therapies?
This review considers current debate surrounding refractory migraine and poses the question, why do some patients fail to improve with currently available therapies?
Dodick
David W
DW
Department of Neurology, Mayo Clinic Arizona, Phoenix, AZ, USA.
D003131:Combined Modality Therapy; D020773:Headache Disorders / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D006801:Humans; D008881:Migraine Disorders / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D010148:Intractable Pain / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D017211:Treatment Failure